Skip to content
Est. 1998 proudly celebrating 27 years of standing behind American companies
American Origin Unverified This profile is unclaimed and has not been independently reviewed. Claim & get verified

PALISADE BIO, INC. (PALI)

$1.95 -3.47% NASDAQ: PALI · 15-min delayed
  • CARLSBAD, California
  • Public · NASDAQ: PALI
  • 14 employees
$302.4MMarket cap
$0Revenue · FY2024
-$16.8MNet income
14Employees
PALINASDAQ
2021IPO

About PALISADE BIO, INC.

Palisade Bio Inc is a clinical-stage biopharma company focused on identifying and developing therapeutics that protect the integrity of the intestinal barrier. Its portfolio consists of a PALI-2108 for the treatment of IBD, including UC and CD, and is researching PALI-1908.

This profile is unclaimed. An authorized representative can claim it to add details and earn the Verified badge.

Reported figures

Financial summary

Revenue FY2024
$0
Net income
-$16.8M
Total assets
$134.3M
Market cap
$302.4M

Source: SEC EDGAR · updated Jun 7, 2026

Multi-year

Revenue & profit trend

Revenue Net income
FY 2025

Financial statements

Income statement

Revenue
$0
Operating expenses
$18.1M
Operating income
-$18.1M
Income tax
$0
Net income
-$16.8M
EPS (basic)
$-0.30
EPS (diluted)
$-0.30

Balance sheet

Total assets
$134.3M
Current assets
$134.2M
Total liabilities
$5.0M
Current liabilities
$4.6M
Shareholders’ equity
$129.4M

Cash flow

Operating cash flow
-$10.8M
Investing cash flow
-$123.6M
Financing cash flow
$134.4M
Net cash flow
$0

Statements via Polygon.io (SEC filings)

NASDAQ: PALI
$1.95 -3.47%

15-minute delayed · data by Polygon.io

Past year · hover for prices

$0.54 $2.80

52-week range

Market cap
$302.4M
EPS (diluted)
$-0.3
Shares outstanding
155.1M
Open
Day range
Prev close
Volume
IPO date
Apr 28, 2021

Palisade BIO, Inc. (PALI) Stock Price

  • Reported a net loss of $16.8M in FY2024.
  • Trading 30% below its 52-week high.

Automatically generated from public filings and market data. Informational only — not investment advice or a recommendation to buy or sell any security.

No reviews yet. Be the first to review PALISADE BIO, INC..

Write a review
Newsroom

News about PALISADE BIO, INC.

News & sentiment via Polygon.io

FAQ

Palisade BIO, Inc.: frequently asked questions

Is Palisade BIO, Inc. an American company?

Palisade BIO, Inc. is a US-based company headquartered in Carlsbad, California, listed in the americancompanies.com directory of American companies. Its American-origin credentials have not yet been independently verified.

Where is Palisade BIO, Inc. headquartered?

Palisade BIO, Inc. is headquartered in Carlsbad, California, United States.

Is Palisade BIO, Inc. publicly traded?

Yes — Palisade BIO, Inc. is a publicly traded company. Its stock trades under the ticker symbol PALI on the NASDAQ.

What does Palisade BIO, Inc. do?

Palisade BIO, Inc. is an American Pharmaceuticals company in the Health & Beauty sector.

Explore

Similar companies

Browse all →